Cargando…

Editorial: Genetic and Epigenetic Mechanisms of Parkinson's Disease

Detalles Bibliográficos
Autores principales:	Li, Song, Le, Weidong, Deng, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019164/ https://www.ncbi.nlm.nih.gov/pubmed/35464312 http://dx.doi.org/10.3389/fnins.2022.842709

Ejemplares similares

Editorial: Genetic and Epigenetic Basis of Neurodegenerative Diseases
por: Yuan, Lamei, et al.
Publicado: (2022)

Entanglement of Genetics and Epigenetics in Parkinson’s Disease
por: van Heesbeen, H. J., et al.
Publicado: (2019)

Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease
por: Hegarty, Shane V., et al.
Publicado: (2020)

Editorial: Genetic and molecular diversity in Parkinson's disease
por: Abdul Murad, Nor Azian, et al.
Publicado: (2022)

Editorial: Epigenetic Mechanisms Regulating Neural Plasticity
por: Ortuño-Sahagún, Daniel, et al.
Publicado: (2019)

Genetic Analysis and Literature Review of SNCA Variants in Parkinson's Disease
por: Guo, Yi, et al.
Publicado: (2021)

Protective Microglia and Their Regulation in Parkinson’s Disease
por: Le, Weidong, et al.
Publicado: (2016)

Editorial: Mechanisms of Epigenetics and Genetics in Leukemogenesis
por: Li, Yonghui, et al.
Publicado: (2022)

Profiling Non-motor Symptoms in Monogenic Parkinson’s Disease
por: Liu, Xinyao, et al.
Publicado: (2020)

Editorial: Integrative Approach to Parkinson's Disease
por: Kim, Seung-Nam, et al.
Publicado: (2019)

Editorial: Sleep disturbances in Parkinson's disease
por: Salsone, Maria, et al.
Publicado: (2023)

MicroRNAs in the epigenetic regulation of disease progression in Parkinson’s disease
por: Selvakumar, Sushmaa Chandralekha, et al.
Publicado: (2022)

Abnormal Vacuole Membrane Protein-1 Expression in Parkinson’s Disease Patients
por: Al-Nusaif, Murad, et al.
Publicado: (2022)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

Genetics and Epigenetics of Parkinson's Disease
por: Coppedè, Fabio
Publicado: (2012)

Editorial: Sound, Music, and Movement in Parkinson’s Disease
por: Bieńkiewicz, Marta M. N., et al.
Publicado: (2016)

Editorial: The Role of Lipids in the Pathogenesis of Parkinson's Disease
por: Baekelandt, Veerle, et al.
Publicado: (2020)

Editorial: Parkinson's disease: cell vulnerability and disease progression
por: Blesa, Javier, et al.
Publicado: (2015)

Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease
por: Li, Tianbai, et al.
Publicado: (2018)

Advances of Mechanisms-Related Metabolomics in Parkinson’s Disease
por: Zhang, Yanyan, et al.
Publicado: (2021)

Editorial: Protein Degradation Pathways in Parkinson's Disease and Neurodegeneration
por: Volta, Mattia, et al.
Publicado: (2020)

Editorial: Mitochondria and Endoplasmic Reticulum Dysfunction in Parkinson’s Disease
por: Barodia, Sandeep Kumar, et al.
Publicado: (2019)

Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinson’s Disease: A Potential Disease Biomarker
por: Yang, Zhaofei, et al.
Publicado: (2019)

Editorial: Highlights in Alzheimer's and Parkinson's disease
por: Cantone, Mariagiovanna, et al.
Publicado: (2023)

The mechanism of exercise for pain management in Parkinson’s disease
por: Yu, Wen-Ye, et al.
Publicado: (2022)

Epigenetic mechanisms in neurological and neurodegenerative diseases
por: Landgrave-Gómez, Jorge, et al.
Publicado: (2015)

Editorial: Stress, pain or drug addiction: epigenetics, biological mechanisms and therapeutics
por: Kim, Hee Young, et al.
Publicado: (2023)

Connectivity and Functionality of the Globus Pallidus Externa Under Normal Conditions and Parkinson's Disease
por: Dong, Jie, et al.
Publicado: (2021)

Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease
por: Greenbaum, Lior, et al.
Publicado: (2013)

New Understanding on the Pathophysiology and Treatment of Constipation in Parkinson’s Disease
por: Xu, Jianli, et al.
Publicado: (2022)

The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson’s disease
por: Chen, Zixuan, et al.
Publicado: (2021)

Editorial: Developmental Abnormalities of Serotonin Homeostasis in Behavioral and Metabolic Disorders: From Epigenetic Mechanisms to Protein Function
por: Hranilovic, Dubravka, et al.
Publicado: (2021)

Editorial: Neurovascular changes in neuroinflammatory diseases
por: Cao, Weidong, et al.
Publicado: (2022)

Editorial: Genetic/epigenetic mechanisms and related clinical strategy in leukemia
por: Li, Yonghui, et al.
Publicado: (2023)

Editorial: The role of epigenetics in neuropsychiatric disorders
por: Shirinian, Margret, et al.
Publicado: (2022)

Prion-Like Mechanisms in Parkinson’s Disease
por: Ma, Jiangnan, et al.
Publicado: (2019)

Epigenetic modification in Parkinson’s disease
por: Song, Hao, et al.
Publicado: (2023)

Genetic and Epigenetic Interplay Define Disease Onset and Severity in Repeat Diseases
por: Barbé, Lise, et al.
Publicado: (2022)

Editorial: Genetics and epigenetics of chronic kidney disease
por: Hoefele, Julia, et al.
Publicado: (2023)

Editorial: Experimental and Innovative Approaches to Multi-Target Treatment of Parkinson's and Alzheimer's Diseases
por: Tikhonova, Maria A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_orirqeu705og2vb3em41j6q528